2549 related articles for article (PubMed ID: 24880031)
1. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
[TBL] [Abstract][Full Text] [Related]
2. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
[TBL] [Abstract][Full Text] [Related]
3. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Tunnicliffe DJ; Palmer SC; Cashmore BA; Saglimbene VM; Krishnasamy R; Lambert K; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD007784. PubMed ID: 38018702
[TBL] [Abstract][Full Text] [Related]
4. HMG CoA reductase inhibitors (statins) for dialysis patients.
Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Nigwekar SU; Hegbrant J; Strippoli GF
Cochrane Database Syst Rev; 2013 Sep; 2013(9):CD004289. PubMed ID: 24022428
[TBL] [Abstract][Full Text] [Related]
5. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
Navaneethan SD; Pansini F; Perkovic V; Manno C; Pellegrini F; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD007784. PubMed ID: 19370693
[TBL] [Abstract][Full Text] [Related]
6. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
7. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
[TBL] [Abstract][Full Text] [Related]
8. Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.
Natale P; Tunnicliffe DJ; Toyama T; Palmer SC; Saglimbene VM; Ruospo M; Gargano L; Stallone G; Gesualdo L; Strippoli GF
Cochrane Database Syst Rev; 2024 May; 5(5):CD015588. PubMed ID: 38770818
[TBL] [Abstract][Full Text] [Related]
9. Statins for the primary prevention of cardiovascular disease.
Taylor F; Huffman MD; Macedo AF; Moore TH; Burke M; Davey Smith G; Ward K; Ebrahim S
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004816. PubMed ID: 23440795
[TBL] [Abstract][Full Text] [Related]
10. Glucose targets for preventing diabetic kidney disease and its progression.
Ruospo M; Saglimbene VM; Palmer SC; De Cosmo S; Pacilli A; Lamacchia O; Cignarelli M; Fioretto P; Vecchio M; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD010137. PubMed ID: 28594069
[TBL] [Abstract][Full Text] [Related]
11. Antioxidants for chronic kidney disease.
Jun M; Venkataraman V; Razavian M; Cooper B; Zoungas S; Ninomiya T; Webster AC; Perkovic V
Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008176. PubMed ID: 23076940
[TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering agents for nephrotic syndrome.
Kong X; Yuan H; Fan J; Li Z; Wu T; Jiang L
Cochrane Database Syst Rev; 2013 Dec; (12):CD005425. PubMed ID: 24327265
[TBL] [Abstract][Full Text] [Related]
13. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD004289. PubMed ID: 19370598
[TBL] [Abstract][Full Text] [Related]
14. HMG CoA reductase inhibitors (statins) for dialysis patients.
Navaneethan SD; Nigwekar SU; Perkovic V; Johnson DW; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Jul; (3):CD004289. PubMed ID: 19588351
[TBL] [Abstract][Full Text] [Related]
15. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
[TBL] [Abstract][Full Text] [Related]
16. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2009 Apr; (2):CD005019. PubMed ID: 19370615
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
18. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
[TBL] [Abstract][Full Text] [Related]
19. Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis.
Palmer SC; Craig JC; Navaneethan SD; Tonelli M; Pellegrini F; Strippoli GF
Ann Intern Med; 2012 Aug; 157(4):263-75. PubMed ID: 22910937
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet agents for chronic kidney disease.
Natale P; Palmer SC; Saglimbene VM; Ruospo M; Razavian M; Craig JC; Jardine MJ; Webster AC; Strippoli GF
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD008834. PubMed ID: 35224730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]